Laura Clague, Chief Financial Officer at Travere Therapeutics, Inc. (TVTX), sold 7,500 shares at $27.40 ($206K) on 2022-01-11, disclosed to the SEC on 2022-01-12.
Open-market sale of $206k TVTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TVTX | SELL | 2022-02-02 | $34K | — | Filing → |
| TVTX | SELL | 2022-01-26 | $103K | — | Filing → |
| TVTX | SELL | 2021-08-17 | $24K | — | Filing → |